MedPath

Comparison between long acting insulin analogue and biphasic insulin aspart30/70 (BIAsp 30) as combination therapy with oral anti-diabetic agents.

Not Applicable
Recruiting
Conditions
Patients with type 2 diabetes mellitus
Registration Number
JPRN-UMIN000005194
Lead Sponsor
ational Hospital Organization, Okayama Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients wiht severe liver or renal injury. Patients in the perioperative period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The level of HbA1cand 1,5-AG. Mean value and coefficient of variance (CVs) obtained from SMBG
Secondary Outcome Measures
NameTimeMethod
body weight and the frequency of hypoglycemia.
© Copyright 2025. All Rights Reserved by MedPath